177 related articles for article (PubMed ID: 34629287)
1. Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis.
Mésinèle J; Ruffin M; Kemgang A; Guillot L; Boëlle PY; Corvol H
J Cyst Fibros; 2022 Jan; 21(1):45-51. PubMed ID: 34629287
[TBL] [Abstract][Full Text] [Related]
2. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis.
Mésinèle J; Ruffin M; Guillot L; Boëlle PY; Corvol H
J Cyst Fibros; 2023 Sep; 22(5):901-908. PubMed ID: 37422431
[TBL] [Abstract][Full Text] [Related]
3. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
[TBL] [Abstract][Full Text] [Related]
4. The determinants of survival among adults with cystic fibrosis-a cohort study.
Durda-Masny M; Goździk-Spychalska J; John A; Czaiński W; Stróżewska W; Pawłowska N; Wlizło J; Batura-Gabryel H; Szwed A
J Physiol Anthropol; 2021 Nov; 40(1):19. PubMed ID: 34749804
[TBL] [Abstract][Full Text] [Related]
5. The effect of Pseudomonas aeruginosa eradication regimens on chronic colonization and clinical outcomes in pediatric patients with cystic fibrosis.
Nayir Buyuksahin H; Yalçın E; Emiralioglu N; Hazırolan G; Ademhan Tural D; Ozsezen B; Sunman B; Guzelkas I; Dogru D; Ozcelik U; Kiper N
Pediatr Int; 2022 Jan; 64(1):e15249. PubMed ID: 36321341
[TBL] [Abstract][Full Text] [Related]
6. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function.
Düesberg U; Wosniok J; Naehrlich L; Eschenhagen P; Schwarz C
Sci Rep; 2020 Nov; 10(1):18999. PubMed ID: 33149181
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of Pseudomonas and Aspergillus co-infected cystic fibrosis patients: A UK registry study.
Hughes DA; Archangelidi O; Coates M; Armstrong-James D; Elborn SJ; Carr SB; Davies JC
J Cyst Fibros; 2022 Jan; 21(1):129-135. PubMed ID: 33958279
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.
Demko CA; Byard PJ; Davis PB
J Clin Epidemiol; 1995 Aug; 48(8):1041-9. PubMed ID: 7775991
[TBL] [Abstract][Full Text] [Related]
10. Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis.
Rosenfeld M; Faino AV; Qu P; Onchiri FM; Blue EE; Collaco JM; Gordon WW; Szczesniak R; Zhou YH; Bamshad MJ; Gibson RL
J Cyst Fibros; 2023 Sep; 22(5):857-863. PubMed ID: 37217389
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.
Dorfman R; Taylor C; Lin F; Sun L; Sandford A; Paré P; Berthiaume Y; Corey M; Durie P; Zielenski J;
Pediatr Pulmonol; 2011 Apr; 46(4):385-92. PubMed ID: 20967843
[TBL] [Abstract][Full Text] [Related]
13. Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis.
Ren CL; Konstan MW; Yegin A; Rasouliyan L; Trzaskoma B; Morgan WJ; Regelmann W;
J Cyst Fibros; 2012 Jul; 11(4):293-9. PubMed ID: 22445849
[TBL] [Abstract][Full Text] [Related]
14. Assessing the health risk of living near composting facilities on lung health, fungal and bacterial disease in cystic fibrosis: a UK CF Registry study.
Khan MS; Douglas P; Hansell AL; Simmonds NJ; Piel FB
Environ Health; 2022 Dec; 21(1):130. PubMed ID: 36517903
[TBL] [Abstract][Full Text] [Related]
15. The impact of chronic pseudomonal infection on pulmonary function testing in individuals with cystic fibrosis in Pretoria, South Africa.
Pentz A; Becker P; Masekela R; Coetzee O; Green RJ
S Afr Med J; 2014 Mar; 104(3):191-4. PubMed ID: 24897822
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide variants in
Saber MM; Donner J; Levade I; Acosta N; Parkins MD; Boyle B; Levesque RC; Nguyen D; Shapiro BJ
Microb Genom; 2023 Apr; 9(4):. PubMed ID: 37052589
[TBL] [Abstract][Full Text] [Related]
17. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes of 'Prairie Epidemic Strain'
Somayaji R; Lam JC; Surette MG; Waddell B; Rabin HR; Sibley CD; Purighalla S; Parkins MD
Thorax; 2017 Apr; 72(4):333-339. PubMed ID: 27682327
[TBL] [Abstract][Full Text] [Related]
19. Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Emond MJ; Louie T; Emerson J; Chong JX; Mathias RA; Knowles MR; Rieder MJ; Tabor HK; Nickerson DA; Barnes KC; ; Go L; Gibson RL; Bamshad MJ
PLoS Genet; 2015 Jun; 11(6):e1005273. PubMed ID: 26047157
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
Ballmann M; Rabsch P; von der Hardt H
Thorax; 1998 Sep; 53(9):732-7. PubMed ID: 10319054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
